|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/24 | |||
| A61K 9/28 | |||
| A61K 31/513 | |||
| A61K 31/675 | |||
| A61P 31/18 |
| (11) | Number of the document | 3316868 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16739625.8 |
| Date of filing the European patent application | 2016-06-29 | |
| (97) | Date of publication of the European application | 2018-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/040158 |
| Date | 2016-06-29 |
| (87) | Number | WO 2017/004244 |
| Date | 2017-01-05 |
| (30) | Number | Date | Country code |
| 201562187113 P | 2015-06-30 | US | |
| 201662298373 P | 2016-02-22 | US | |
| 201662301429 P | 2016-02-29 | US | |
| 201662317286 P | 2016-04-01 | US |
| (72) |
KOZIARA, Joanna, M., US
MCCALLISTER, Scott, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR AND EMTRICITABINE |
| PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR AND EMTRICITABINE |